| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.18 | 0.0005 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.13 | 0.003 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.091 | 0.008 |